The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis

Blood Purification

Volumn 41, Issue 1-3, 2016, Pages 34-40

  Clementi, Anna ^a,d   Virzì, Grazia Maria ^a,b   Brocca, Alessandra ^a,b,c   Pastori, Silvia ^a,b   De Cal, Massimo ^a,b   Marcante, Stefano ^b   Granata, Antonio ^d   Ronco, Claudio ^a,d  

^a International Renal Research Institute (IRRIV)   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^d SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

Apoptosis; Cell free DNA; Outcome; Sepsis

Indexed keywords

CASPASE 3; CELL FREE PLASMA DNA; DNA; INTERLEUKIN 18; INTERLEUKIN 6; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CASP3 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 18 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; MYCOSIS; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; ACUTE KIDNEY INJURY; AGED; BLOOD; COMPLICATION; CRITICAL ILLNESS; GENE EXPRESSION; GENETICS; INTENSIVE CARE UNIT; MORTALITY; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; VERY ELDERLY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CASPASE 3; CRITICAL ILLNESS; DNA; FEMALE; GENE EXPRESSION; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RENAL REPLACEMENT THERAPY; SEPSIS; SURVIVAL ANALYSIS;

EID: 84945134210     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000440975     Document Type: Article

References (31)

1. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2013; 93: 329-342.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
3. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108-121.
4. Ventetuolo CE, Levy MM: Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008; 29: 591-603, vii.
5. Meisner M: Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005; 11: 473-480.
6. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P: About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001; 313: 139-142.
7. Lichtenstein AV, Melkonyan HS, Tomei LD, Umansky SR: Circulating nucleic acids and apoptosis. Ann N Y Acad Sci 2001; 945: 239-249.
8. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA: Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46: 319-323.
9. Wu TL, Zhang D, Chia JH, Tsao K-, Sun CF, Wu JT: Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 2002; 321: 77-87.
10. Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, et al: Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003; 49: 562-569.
11. Chang CP, Chia RH, Wu TL, Tsao KC, Sun CF, Wu JT: Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 2003; 327: 95-101.
12. Saukkonen K, Lakkisto P, Pettilä V, Varpula M, Karlsson S, Ruokonen E, et al: Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008; 54: 1000-1007.
13. Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, et al: Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947-1951.
14. Fuentes-Prior P, Salvesen GS: The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004; 384(pt 2):201-232.
15. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE: Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 2005; 174: 5110-5118.
16. Aziz M, Jacob A, Wang P: Revisiting caspases in sepsis. Cell Death Dis 2014; 5:e1526.
17. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.
18. Ricci Z, Cruz DN, Ronco C: Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol 2011; 7: 201-208.
19. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al: Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772.
20. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED: Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006; 10:R60.
21. Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki LM, Pettilä V, et al: Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med 2007; 33: 1624-1627.
22. Wijeratne S, Butt A, Burns S, Sherwood K, Boyd O, Swaminathan R: Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci 2004; 1022: 232-238.
23. Moreira VG, Prieto B, Rodríguez JS, Alvarez FV: Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 2010; 47(pt 3):253-258.
24. Fournié GJ, Courtin JP, Laval F, Chalé JJ, Pourrat JP, Pujazon MC, et al: Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995; 91: 221-227.
25. Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6: 813-822.
26. Ueda N, Shah SV: Tubular cell damage in acute renal failure-apoptosis, necrosis, or both. Nephrol Dial Transplant 2000; 15: 318-323.
27. Sanz AB, Santamaría B, Ruiz-Ortega M, Egido J, Ortiz A: Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634-1642.
28. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520.
29. Nijsten MW, Hack CE, Helle M, ten Duis HJ, Klasen HJ, Aarden LA: Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 1991; 109: 761-767.
30. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, et al: Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-1710.
31. Ogura Y, Sutterwala FS, Flavell RA: The inflammasome: first line of the immune response to cell stress. Cell 2006; 126: 659-662.